Xin Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Klebsiella Pneumoniae

Ultra High Performance Liquid Chromatography

Top Venues

Molecular cancer therapeutics

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Sitanshu S Singh, Raul Calvo, Anju Kumari, Rushikesh V Sable, Yuhong Fang, Dingyin Tao, Xin Hu, Sarah Gray Castle, Saifun Nahar, Dandan Li, Emily Major, Tino W Sanchez, Rintaro Kato, Xin Xu, Jian Zhou, Liang Liu, Christopher A LeClair, Anton Simeonov, Bolormaa Baljinnyam, Mark J Henderson, Juan Jose Marugan, Rushikesh Sable
Fatty acid derivatization and cyclization of the immunomodulatory peptide RP-182 targeting CD206high macrophages improves anti-tumor activity. Molecular cancer therapeutics (2024)
Courtney L Finch, Julie Dyall, Shuang Xu, Elizabeth A Nelson, Elena Postnikova, Janie Y Liang, Huanying Zhou, Lisa Evans DeWald, Craig J Thomas, Amy Wang, Xin Xu, Emma Hughes, Patrick J Morris, Jon C Mirsalis, Linh H Nguyen, Maria P Arolfo, Bryan Koci, Michael R Holbrook, Lisa E Hensley, Peter B Jahrling, Connie Schmaljohn, Lisa M Johansen, Gene G Olinger, Joshua T Schiffer, Judith M White
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo. Microorganisms 9 (3) (2021)
Kirill Gorshkov, Amy Q Wang, Wei Sun, Ethan Fisher, Marta Frigeni, Marc Singleton, Natasha Thorne, Bradley Class, Wenwei Huang, Nicola Longo, Minh-Ha T Do, Elizabeth A Ottinger, Xin Xu, Wei Zheng
Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts. Pharmacology research & perspectives 7 (6) (2020)